Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Vakoc

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Nature Communications|December 15, 2023
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57<sup>Kip2</sup> targetingSilvia Pomella, Matteo Cassandri, Lucrezia D'Archivio, et al.
Nature Chemical Biology|July 10, 2019
Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3Jark Böttcher, David Dilworth, Ulrich Reiser, et al.
Science Signaling|November 22, 2018
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
Nature Communications|June 22, 2019
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaCharles C Bell, Katie A Fennell, Yih-Chih Chan, et al.
Cancers|March 28, 2026
Biological Advances and Current Challenges for Pediatric RhabdomyosarcomaKatie E Hebron, Patience Odeniyide, Yun Wei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2020
New Approaches to SCLC Therapy: From the Laboratory to the ClinicJohn T Poirier, Julie George, Taofeek K Owonikoko, et al.
Science (New York, N.Y.)|October 24, 2024
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 functionManojit M Swamynathan, Shan Kuang, Kaitlin E Watrud, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Nature Communications|December 15, 2023
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57<sup>Kip2</sup> targetingSilvia Pomella, Matteo Cassandri, Lucrezia D'Archivio, et al.
Nature Chemical Biology|July 10, 2019
Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3Jark Böttcher, David Dilworth, Ulrich Reiser, et al.
Science Signaling|November 22, 2018
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
Nature Communications|June 22, 2019
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaCharles C Bell, Katie A Fennell, Yih-Chih Chan, et al.
Cancers|March 28, 2026
Biological Advances and Current Challenges for Pediatric RhabdomyosarcomaKatie E Hebron, Patience Odeniyide, Yun Wei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2020
New Approaches to SCLC Therapy: From the Laboratory to the ClinicJohn T Poirier, Julie George, Taofeek K Owonikoko, et al.
Science (New York, N.Y.)|October 24, 2024
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 functionManojit M Swamynathan, Shan Kuang, Kaitlin E Watrud, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Pageof 14